Abstract

Respiratory Allergy in Elderly: The Role of Specific Immunotherapy

Maurizio Marogna *

The role of specific immunotherapy (AIT) in elderly allergic patients is still debated. Very few studies specifically addressing the efficacy of AIT in the elderly can be found in the medical literature. On the basis of these trials, injection AIT (SCIT) can be considered an effective therapeutic option in otherwise healthy older patients with a short disease duration whose symptoms cannot be adequately controlled by drug therapies alone. Equally sublingual AIT (SLIT) reduces symptoms, drug consumption and the progression of the disease in both young and elderly allergic subjects with persistent rhinitis and mild bronchial asthma as long as the disease had started fairly recently.

Published Date: 2020-11-30; Received Date: 2020-11-09